SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001355250-13-000032
Filing Date
2013-09-09
Accepted
2013-09-09 11:25:10
Documents
5
Period of Report
2013-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 reportpoly_8k.htm 8-K 41169
2 pressrelease_99z1.htm EX-99.1 9006
3 exhibit_2z1.htm EX-2.1 145233
4 exhibit_2z2.htm EX-2.2 13587
5 exhibit_2z3.htm EX-2.3 68573
  Complete submission text file 0001355250-13-000032.txt   278859
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-52321 | Film No.: 131084732
SIC: 2834 Pharmaceutical Preparations